The Government have today announced a number of loan competitions worth up to £150 million to support research and development projects from the UK’s most innovative businesses. Funded by Innovate UK, the scheme aims to supports projects which are determined to have the greatest chance of bolstering future economic growth while concurrently tackling social challenges.The Government views this initiative as key to supporting the plans set out in the Innovation Strategy, which was rele...

Health and Social Care Secretary Sajid Javid attended the CEPI Global Pandemic Preparedness Summit 2022 this Tuesday 8 March where he made a speech on the UK’s readiness to react to public health threats as well as the required focus on vaccinations and diagnostics.CEPI is an innovative global partnership between public, private, philanthropic, and civil society organisations. It works to accelerate the development of vaccines against emerging infectious diseases and enable equitable acces...

This new campaign’s novel approach focuses on tackling the fear of cancer itself rather than specific symptoms to try to detect cancers early. Its key message, which will run across both traditional and social media, is: if you feel something is wrong, then get checked. The aim of this is to give patients peace of mind or, if something is indeed wrong, the best chance of successful treatment through an early diagnosis.NHS data has shown that anxiety about cancer is widespread and can have ...

The Government has stated that £200 million will be spent on making NHS data more readily available for research and increasing its security and accessibility. It is hoped that this will allow the NHS to deliver innovative new treatments faster and increase diversity in clinical trials to combat existing health inequalities.In a further boost to the life sciences sector, the remaining money will be used to create a £60 million Life Sciences Innovative Manufacturing Fund (LSIMF). The ...

RQM+, the world’s leading provider of regulatory, clinical and quality solutions to the MedTech industry, today announced the appointment of Margaret Keegan as CEO. Keegan succeeds co-founder Maria Fagan, who is retiring and will join the board of directors as vice chair.

BIVDA, the UK’s leading association for in vitro diagnostic (IVD) technology and innovation, welcomes the £200 million in funding announced by BEIS and DHSC to support critical health research into diagnostics and treatment through enhanced data access and digital clinical trial services. Following on from the Medicines and Diagnostics Manufacturing Transformation Fund, a new £60 million Life Sciences Innovative Manufacturing Fund (LSIMF) will help to broaden the commercial-sca...

BIVDA welcomes today’s announcement by NHS chief executive Amanda Pritchard of a new campaign which encourages the public to get tested early if they fear they may have cancer.

 Rare Disease Day is taking place today, Monday 28 February 2022, and is an important opportunity to support people living with rare or undiagnosed conditions, and to take stock of the UK’s progress in facilitating better diagnostic approaches, charity funding and legislation to improve outcomes. On Rare Disease Day, 106 countries worldwide host more than 600 events to draw attention to these conditions and patients. Around 300 million globally are living with rare or undiagnosed dise...

The Government’s plans to establish a minimum of 100 community diagnostic centres (CDCs) across the country face major difficulties as medical leaders have warned that they lack the 6,000 staff necessary to run them. Health Minister Edward Argar has previously confirmed that CDCs will require an extra 3,500 radiographers, 2,000 radiologists and 500 senior nurses in order to operate.This news comes at a time when the NHS already faces a crippling workforce crisis, and many senior figures ar...

FluoretiQ Limited the award-winning start-up, pioneering NANOPLEX a 15-minute proprietary diagnostic platform for bacterial infections today announced the completion of a £1.1 million, pre-series A investment